JP2001058953A - Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production - Google Patents

Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production

Info

Publication number
JP2001058953A
JP2001058953A JP11234436A JP23443699A JP2001058953A JP 2001058953 A JP2001058953 A JP 2001058953A JP 11234436 A JP11234436 A JP 11234436A JP 23443699 A JP23443699 A JP 23443699A JP 2001058953 A JP2001058953 A JP 2001058953A
Authority
JP
Japan
Prior art keywords
lees
extract
rice bran
sake
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11234436A
Other languages
Japanese (ja)
Inventor
Sogen Kin
宗鉉 金
Koichiro Muramatsu
浩一郎 村松
Hiroshige Himawari
博重 樋▲廻▼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aioi Hakko KK
Original Assignee
Aioi Hakko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aioi Hakko KK filed Critical Aioi Hakko KK
Priority to JP11234436A priority Critical patent/JP2001058953A/en
Publication of JP2001058953A publication Critical patent/JP2001058953A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain an apoptosis inducer consisting of an organic solvent extract from sake-lees or rice bran fermented extract lees, easily takable without any anxiety similarly to foods, and useful as a prophylactic/therapeutic agent for cancer. SOLUTION: This apoptosis inducer which consists of an organic solvent extract from sake-lees or rice bran fermented extract lees, is obtained, preferably by adding an organic solvent (pref. ethanol) to sake-lees or rice bran fermented extract lees, agitating the mixture while grinding and heating to effect extraction followed by centrifugal separation to obtain a supernatant, which, in turn, is concentrated e.g. under reduced pressures. The extract thus obtained can be daily taken similarly to sports drinks or tea after processed for drinks, or can also be taken as a health food or the like through addition to food; furthermore, the extract can be processed into a form suitable for intake through processing into capsules, tablets, syrups and the like as the case with vitamin preparations or the like.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】この発明は、酒粕又は米糠発
酵エキス粕よりなるアポトーシス誘導物質及びその製法
に関し、特には、酒粕や米糠発酵エキス粕を原料として
得られる癌予防剤および治療剤として有用な物質に関す
る。
TECHNICAL FIELD The present invention relates to an apoptosis-inducing substance composed of sake lees or fermented rice bran extract and a method for producing the same, and particularly useful as a cancer preventive and therapeutic agent obtained from sake lees or fermented rice bran extract. About the substance.

【0002】[0002]

【従来の技術】現在、癌は死亡原因のトップの病気であ
り、その予防や治療に対する人々の関心は非常に高い。
また、日常的に取り入れることができる癌予防および治
療のための方法が数多く提案されている。
2. Description of the Related Art At present, cancer is the leading cause of death, and people are very interested in its prevention and treatment.
Also, a number of methods for cancer prevention and treatment that can be routinely adopted have been proposed.

【0003】近年、癌研究の分野ではアポトーシス、す
なわち細胞自滅に関する研究が盛んに行われている。ア
ポトーシスは生物個体発生における組織、臓器の形成、
生体の恒常性の維持と防衛に重要な働きをしているだけ
ではなく、多くの病気の発生に深い関係があることが解
明されつつある。
In recent years, studies on apoptosis, that is, cell self-destruction, have been actively conducted in the field of cancer research. Apoptosis is the formation of tissues and organs during biological ontogeny,
It is being elucidated that not only plays an important role in maintaining and defending the homeostasis of living organisms but also has a deep relationship with the occurrence of many diseases.

【0004】アポトーシスによる細胞の制御作用の異常
は、癌形成の一つの原因であると考えられている。本来
死滅すべき細胞がアポトーシス、つまり細胞自滅を起こ
すことなく生き残ると、その細胞が様々な刺激を受けて
染色体上に変異を重ね、最終的に癌細胞になるとされて
いる。癌細胞は、アポトーシスへの耐性機構を獲得して
初めて増殖を可能にするのである。すなわち、癌はアポ
トーシス機構が衰退したために生じる病気である。この
ことから、種々の遺伝子変異を伴う細胞の癌化の過程は
アポトーシスに対する耐性能獲得の過程に関係がある。
[0004] Abnormal control of cells by apoptosis is considered to be one of the causes of cancer formation. It is said that if cells that should be killed survive without causing apoptosis, that is, cell self-destruction, the cells will receive various stimuli and repeat mutations on the chromosome, eventually becoming cancer cells. Cancer cells can only proliferate after acquiring a resistance mechanism to apoptosis. That is, cancer is a disease caused by the decline of the apoptotic mechanism. From this, the process of canceration of cells with various gene mutations is related to the process of acquiring resistance to apoptosis.

【0005】アポトーシスが正常に機能するためには、
アポトーシス誘導を刺激する要因が必要である。この要
因により、最終的に細胞死滅の実行過程を活性化し、ア
ポトーシスが起きるとされている。
For apoptosis to function properly,
Factors that stimulate apoptosis induction are required. It is said that this factor ultimately activates the process of cell killing and causes apoptosis.

【0006】多くの抗癌剤が癌細胞のアポトーシス誘導
刺激となる要因であることが知られている。ところが、
抗癌剤は適当な使用量や使用期間等を設定することが困
難であり、さらにその副作用は癌患者にとって大きな負
担となるものである。
[0006] It is known that many anticancer agents are factors that stimulate apoptosis of cancer cells. However,
It is difficult to set an appropriate amount and period of use of the anticancer agent, and further, its side effects impose a heavy burden on cancer patients.

【0007】[0007]

【発明が解決しようとする課題】アポトーシス誘導刺激
となる要因の究明は癌の予防と治療に対して非常に重要
である。
It is very important for the prevention and treatment of cancer to determine factors that induce apoptosis.

【0008】そこでこの発明は、アポトーシス誘導刺激
となる物質に注目し、酒粕や米糠発酵エキス粕に含まれ
る成分を有機溶媒で抽出したものからアポトーシス誘導
物質を見いだそうとするものである。
Therefore, the present invention focuses on a substance that is a stimulus for inducing apoptosis, and seeks to find an apoptosis-inducing substance from components extracted from sake lees and fermented rice bran extract with an organic solvent.

【0009】[0009]

【課題を解決するための手段】すなわち本発明は、請求
項1において、酒粕又は米糠発酵エキス粕の有機溶媒抽
出物よりなることを特徴とする酒粕又は米糠発酵エキス
粕よりなるアポトーシス誘導物質に係る。
That is, the present invention relates to an apoptosis-inducing substance comprising sake lees or rice bran fermented extract lees, which is characterized in that it comprises an organic solvent extract of sake lees or fermented rice bran extract lees. .

【0010】また、請求項2の発明は、酒粕又は米糠発
酵エキス粕に有機溶媒を加えて攪拌し抽出し、その後遠
心分離して上清を得、該上清を濃縮することを特徴とす
る酒粕又は米糠発酵エキス粕よりなるアポトーシス誘導
物質の製法に係る。
[0010] The invention of claim 2 is characterized in that an organic solvent is added to sake lees or fermented rice bran extract, stirred and extracted, and then centrifuged to obtain a supernatant, and the supernatant is concentrated. The present invention relates to a method for producing an apoptosis-inducing substance composed of sake lees or fermented rice bran extract lees.

【0011】[0011]

【発明の実施の形態】以下添付の図面に従ってこの発明
を詳細に説明する。図1はこの発明の一実施例を示す概
略工程図、図2は実験1の酒粕のエタノール抽出物によ
る癌細胞の増殖抑制作用を示すグラフ、図3は実験2の
酒粕のエタノール抽出物によって断片化されたDNAの分
布状態を示す模式図、図4は実験3の米糠発酵エキス粕
のエタノール抽出物による癌細胞の増殖抑制作用を示す
グラフ、図5は実験4の米糠発酵エキス粕のエタノール
抽出物によって断片化されたDNAの分布状態を示す模式
図である。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail with reference to the accompanying drawings. FIG. 1 is a schematic process chart showing one embodiment of the present invention, FIG. 2 is a graph showing the inhibitory effect of the ethanol extract of sake lees of Experiment 1 on the growth of cancer cells, and FIG. FIG. 4 is a schematic diagram showing the distribution of the converted DNA, FIG. 4 is a graph showing the inhibitory effect of cancer extract on the ethanol extract of the rice bran fermented extract extract in Experiment 3, and FIG. It is a schematic diagram which shows the distribution state of the DNA fragmented by the thing.

【0012】本件発明は、酒粕又は米糠発酵エキス粕の
有機溶媒抽出物よりなることを特徴とする酒粕又は米糠
発酵エキス粕よりなるアポトーシス誘導物質であり、該
アポトーシス誘導物質の作用により、癌細胞の増殖を抑
制しようとするものである。
The present invention relates to an apoptosis-inducing substance consisting of sake lees or rice bran fermented extract lees, which comprises an organic solvent extract of sake lees or fermented rice bran extract lees. It is intended to suppress proliferation.

【0013】本件発明の一実施例として、白米等を原料
とした酒製造の副産物である酒粕や、米糠を発酵させて
得られる入浴剤等の副産物である米糠発酵エキス粕を用
いる。前記酒粕や米糠発酵エキス粕中の成分を取り出す
ために、有機溶媒を用いて抽出をおこなう。この有機溶
媒はアルコール等の脂溶性のものが好ましく、特にエタ
ノールは人体への安全性が高く溶媒を完全に除去するこ
とが不要になる点で望ましい溶媒である。
In one embodiment of the present invention, sake lees, a by-product of sake production using white rice and the like as a raw material, and fermented rice bran extract lees, a by-product of a bath preparation obtained by fermenting rice bran, are used. Extraction is performed using an organic solvent in order to remove the components in the sake lees and the rice bran fermented extract lees. The organic solvent is preferably a fat-soluble one such as alcohol. Particularly, ethanol is a desirable solvent because it is highly safe for the human body and it is not necessary to completely remove the solvent.

【0014】酒粕又は米糠発酵エキス粕よりなるアポト
ーシス誘導物質の製法は次のように行われる。酒粕又は
米糠発酵エキス粕に有機溶媒を加えて前記酒粕又は米糠
発酵エキス粕の粉砕および加熱をしながら一定時間撹拌
する。有機溶媒によって酒粕又は米糠発酵エキス粕の成
分が抽出される。続いて、遠心分離して上清を得る。そ
して、この上清を減圧濃縮等によって濃縮する。なお、
適宜溶媒による稀釈および濾過滅菌を行ってもよい。
The method for producing an apoptosis-inducing substance consisting of sake lees or fermented rice bran extract lees is performed as follows. An organic solvent is added to the sake lees or the rice bran extract extract lees, and the sake lees or the rice bran fermented extract lees are stirred for a certain period of time while being ground and heated. The components of sake lees or fermented rice bran extract lees are extracted by the organic solvent. Subsequently, centrifugation is performed to obtain a supernatant. Then, the supernatant is concentrated by vacuum concentration or the like. In addition,
Dilution with a solvent and filtration sterilization may be performed as appropriate.

【0015】上記の製法により、酒粕又は米糠発酵エキ
ス粕から有機溶媒抽出物を得ることができ、例えば飲料
用に加工して、スポーツドリンクやお茶と同様の感覚で
日常的に摂取したり、食品に添加して健康食品等として
前記抽出物を摂取することもできる。また、前記抽出物
は、ビタミン剤等のようにカプセルや錠剤、シロップ状
等に加工することにより意識的に前記抽出物を摂取でき
る形態に加工することもできる。
By the above-mentioned production method, an organic solvent extract can be obtained from sake lees or rice bran fermented extract lees. For example, it can be processed into a beverage and ingested on a daily basis with the same feeling as a sports drink or tea. The extract can be ingested as a health food or the like by adding the extract. Further, the extract can be processed into capsules, tablets, syrups, and the like, such as vitamin preparations, so that the extract can be consciously processed.

【0016】[0016]

【実施例】酒粕又は米糠発酵エキス粕を原料として得ら
れる有機溶媒抽出物のアポトーシス誘導物質の作用を確
認するための実施例を以下に示し、図1の概略工程図に
従って説明する。
EXAMPLE An example for confirming the action of an apoptosis-inducing substance of an organic solvent extract obtained from sake lees or rice bran fermented extract lees as a raw material is shown below, and will be described with reference to the schematic process diagram of FIG.

【0017】(実施例1)酒粕を原料として実施例1を
行った。酒粕10gにアルコール度50%のエタノール
を90ml加えて室温で5分間ホモジナイズした。50
〜60℃に温度を保ちながら、5時間撹拌を行った。こ
れを4℃で10分間、9000×gで遠心分離し、上清
液を得た。得られた上清液を50℃で3時間、エバポレ
ーターで減圧濃縮した。得られた濃縮物をアルコール度
50%のエタノールに溶解し、ミリポアフィルター
(0.22μm)で濾過滅菌した。
Example 1 Example 1 was performed using sake lees as a raw material. To 10 g of sake lees, 90 ml of ethanol having an alcohol content of 50% was added and homogenized at room temperature for 5 minutes. 50
While maintaining the temperature at 6060 ° C., stirring was performed for 5 hours. This was centrifuged at 9000 × g at 4 ° C. for 10 minutes to obtain a supernatant. The obtained supernatant was concentrated under reduced pressure at 50 ° C. for 3 hours using an evaporator. The obtained concentrate was dissolved in ethanol having an alcohol content of 50%, and sterilized by filtration through a Millipore filter (0.22 μm).

【0018】なお、本実施例では有機溶媒としてアルコ
ール度が50%のエタノールを用いているが、酒粕や米
糠発酵エキス粕中の成分の抽出には、40〜60%のア
ルコール度の範囲内であればよい。
In this embodiment, ethanol having an alcohol content of 50% is used as the organic solvent. However, extraction of the components in the sake lees and the rice bran fermented extract lees is carried out within the range of alcohol content of 40 to 60%. I just need.

【0019】このようにして得られた酒粕のエタノール
抽出物を用い、これに含まれるアポトーシス誘導物質の
作用による癌細胞の増殖抑制作用を調べるために実験1
及び実験2を行った。
Using the ethanol extract of sake lees thus obtained, an experiment was carried out to examine the effect of the apoptosis-inducing substance contained therein to inhibit the growth of cancer cells.
And Experiment 2 were performed.

【0020】(実験1)ヒトリンパ性白血病Molt
4B細胞を10%牛血清とペニシリンG(50IU/m
l)及びストレプトマイシン(50 μg/ml)が含
まれたRPMI1640培地で培養した。4〜5×10
cells/mlのヒトリンパ性白血病Molt 4
B細胞に50%エタノール(対照サンプル用)、酒粕5
0%エタノール抽出物(実験サンプル用)をそれぞれ添
加し、37℃、95%空気と5% C0で培養し、対照
サンプル及び、実験サンプル及びを得た。3日
後に、ヒトリンパ性白血病Molt 4B細胞数を血球
計算板で数え、細胞の増殖抑制率を求めた。その結果を
図2に示す。なお、実験サンプルは、酒粕の抽出物が
前記ヒトリンパ性白血病Molt 4B細胞浮遊液に対
して2mg/mlになるように、また実験サンプルは
4mg/mlになるように調製されたものである。
(Experiment 1) Human lymphocytic leukemia Molt
4B cells were treated with 10% bovine serum and penicillin G (50 IU / m
1) and streptomycin (50 μg / ml) in RPMI1640 medium. 4-5 × 10
5 cells / ml human lymphocytic leukemia Molt 4
50% ethanol for B cells (for control sample), sake lees 5
A 0% ethanol extract (for an experimental sample) was added to each, and the mixture was cultured at 37 ° C., 95% air and 5% CO 2 to obtain a control sample and an experimental sample. Three days later, the number of human lymphocytic leukemia Molt 4B cells was counted using a hemocytometer, and the cell growth inhibition rate was determined. The result is shown in FIG. The experimental sample was prepared so that the extract of sake lees was 2 mg / ml with respect to the human lymphoid leukemia Molt 4B cell suspension, and the experimental sample was 4 mg / ml.

【0021】なお、ヒトリンパ性白血病Molt 4B
細胞はヒト急性リンパ芽球性白血病由来の癌細胞であ
る。
The human lymphocytic leukemia Molt 4B
The cells are cancer cells derived from human acute lymphoblastic leukemia.

【0022】(実験2)ヒトリンパ性白血病Molt
4B細胞の4〜5×10cells/mlに次に示
すものをそれぞれ添加して3日間培養し、サンプルか
らを得た。及びは対照サンプル、また及びは
実験サンプルである。 50%エタノールを前記ヒトリンパ性白血病Mol
t 4B細胞の浮遊液に加えて、10μl/mlになる
ように調製したもの。 50%エタノールを前記ヒトリンパ性白血病Mol
t 4B細胞の浮遊液に加えて、20μl/mlになる
ように調製したもの。 酒粕エタノール抽出物を前記ヒトリンパ性白血病M
olt 4B細胞の浮遊液に加えて、2mg/mlにな
るように調整したもの。 酒粕エタノール抽出物を前記ヒトリンパ性白血病M
olt 4B細胞の浮遊液に加えて、4mg/mlにな
るように調整したもの。
(Experiment 2) Human lymphocytic leukemia Molt
The following were added to 4-5 × 10 5 cells / ml of 4B cells, respectively, and cultured for 3 days to obtain samples. And are control samples, and and are experimental samples. 50% ethanol was added to the human lymphocytic leukemia Mol
t4B cells were added to the suspension and adjusted to 10 μl / ml. 50% ethanol was added to the human lymphocytic leukemia Mol
t4B cells were added to the suspension and adjusted to 20 μl / ml. The ethanol extract of sake lees was used for the human lymphocytic leukemia M
What was added to the suspension of olt 4B cells and adjusted to 2 mg / ml. The ethanol extract of sake lees was used for the human lymphocytic leukemia M
What was added to the suspension of olt 4B cells and adjusted to 4 mg / ml.

【0023】培養したそれぞれからのサンプルを、
遠心分離(3000×g、5分間)し、上清を除去した
後に残った細胞を採集した。この細胞はPBS(―)で
一回洗浄を行った。細胞ペレットに細胞融解用バッファ
ーを20μl加え、細胞を融解させた。RNase A
溶液を加え、50℃で2.5時間反応させてからプロテ
イナーゼ K液を加え、50℃で2.5時間反応させ、
DNA断片を抽出した。DNA抽出液10μlとゲルロ
ーディング液2〜3μlを混合して、2%アガロースゲ
ル板のウエルに添加し、100Vで電気泳動を行った。
電気泳動後、ゲルを水に浸してから、UVトランスイル
ミネーターでエチジウムブロマイド蛍光を発するDNA
を検出した。その後写真撮影し、その写真を模式的に図
3に示した。なお、図3で示すMはDNA分子量マーカ
ーである。
The samples from each of the cultured
After centrifugation (3000 × g, 5 minutes), the cells remaining after removing the supernatant were collected. The cells were washed once with PBS (-). 20 μl of a cell lysis buffer was added to the cell pellet to lyse the cells. RNase A
The solution was added, reacted at 50 ° C. for 2.5 hours, and then proteinase K solution was added, and reacted at 50 ° C. for 2.5 hours.
The DNA fragment was extracted. 10 µl of the DNA extract and 2-3 µl of the gel loading solution were mixed, added to the wells of a 2% agarose gel plate, and electrophoresed at 100V.
After electrophoresis, the gel is immersed in water, and then DNA that emits ethidium bromide fluorescence with a UV transilluminator.
Was detected. Thereafter, a photograph was taken, and the photograph is schematically shown in FIG. Note that M shown in FIG. 3 is a DNA molecular weight marker.

【0024】実施例1により、酒粕のエタノール抽出物
中には、ヒトリンパ性白血病Molt 4B細胞の増殖
を抑制する成分、すなわちアポトーシス誘導物質が含ま
れていることが理解される。また、ヒトリンパ性白血病
Molt 4B細胞へのアポトーシス誘導物質の添加量
が多いほど、増殖抑制作用が高くなっている。
From Example 1, it is understood that the ethanol extract of sake lees contains a component that suppresses the proliferation of human lymphocytic leukemia Molt 4B cells, that is, an apoptosis-inducing substance. In addition, the larger the amount of the apoptosis-inducing substance added to human lymphocytic leukemia Molt 4B cells, the higher the growth inhibitory effect.

【0025】(実施例2)次に、米糠発酵エキス粕を原
料として実施例2を行った。実施例2は、原料を米糠発
酵エキス粕で行った以外は実施例1と同様の方法で行っ
た。得られた米糠発酵エキス粕のエタノール抽出物を用
いてヒトリンパ性白血病Molt 4B細胞の増殖抑制
作用を調べるために、実験3及び実験4を行った。
(Example 2) Next, Example 2 was performed using fermented rice bran extract lees as a raw material. Example 2 was performed in the same manner as in Example 1 except that the raw material was fermented rice bran extract cake. Experiments 3 and 4 were performed to examine the growth inhibitory effect of human lymphocytic leukemia Molt 4B cells using the obtained ethanol extract of the rice bran fermented extract cake.

【0026】(実験3)実験1と同様の方法で行った。
実験に用いたサンプルは、及びの対照サンプルは実
験1と同様のものであり、及びの実験サンプルは4
〜5×10cells/mlのヒトリンパ性白血病M
olt 4B細胞に米糠発酵エキス粕50%エタノール
抽出物を添加したものである。なお、実験サンプル
は、米糠発酵エキス粕のエタノール抽出物が前記ヒトリ
ンパ性白血病Molt 4B細胞浮遊液に対して1.7
5mg/mlになるように、また実験サンプルは3.
5mg/mlになるように調製されたものである。その
実験結果を図4に示す。
(Experiment 3) The experiment was performed in the same manner as in Experiment 1.
The sample used for the experiment, and the control sample were the same as in Experiment 1, and the experimental sample was 4
~ 5 × 10 5 cells / ml human lymphocytic leukemia M
It is a rice bran fermented extract lees 50% ethanol extract added to olt 4B cells. In addition, in the experimental sample, the ethanol extract of the rice bran fermented extract lees was 1.7 with respect to the human lymphocytic leukemia Molt 4B cell suspension.
5 mg / ml, and the experimental sample was 3.
It was prepared to be 5 mg / ml. FIG. 4 shows the experimental results.

【0027】(実験4)実験2と同様の方法で行った。
用いたサンプルからにつていは、及びは実験2
と同様の対照サンプル、または米糠発酵エキス粕エタ
ノール抽出物を前記ヒトリンパ性白血病Molt 4B
細胞浮遊液に添加して1.75mg/mlになるように
加えたもの、は米糠発酵エキス粕エタノール抽出物を
3.5mg/mlになるように加えたものである。その
実験結果を図5に示す。
(Experiment 4) The experiment was performed in the same manner as in Experiment 2.
For the samples used, and
The same control sample as above or the ethanol extract of rice bran fermented extract lees was used for the human lymphocytic leukemia Molt 4B
The one added to the cell suspension to a concentration of 1.75 mg / ml is the one obtained by adding the ethanol extract of the rice bran fermented extract lees to a concentration of 3.5 mg / ml. FIG. 5 shows the experimental results.

【0028】以上の実施例2より、米糠発酵エキス粕の
エタノール抽出物によって、ヒトリンパ性白血病Mol
t 4B細胞の増殖抑制作用が確認される。
From Example 2 above, the ethanol extract of the rice bran fermented extract lees was used to prepare human lymphocytic leukemia Mol.
The effect of suppressing the growth of t4B cells is confirmed.

【0029】つまり、米糠発酵エキス粕のエタノール抽
出物に含まれるアポトーシス誘導物質の作用によるヒト
リンパ性白血病Molt 4B細胞の増殖抑制作用が、
実施例1で示す酒粕を用いた場合と同じように確認され
る。
In other words, the effect of the apoptosis-inducing substance contained in the ethanol extract of the rice bran fermented extract lees to suppress the proliferation of human lymphocytic leukemia Molt 4B cells is as follows:
It is confirmed in the same manner as when the sake lees shown in Example 1 is used.

【0030】また、実施例1及び実施例2では酒粕また
は米糠発酵エキス粕を単独で用いたが、酒粕と米糠発酵
エキス粕とを混合して用いてもよい。
Although the sake lees or the rice bran fermented extract lees were used alone in Examples 1 and 2, the sake lees and the rice bran fermented extract lees may be mixed and used.

【0031】[0031]

【発明の効果】以上図示し説明したように、この発明の
酒粕又は米糠発酵エキス粕よりなるアポトーシス誘導物
質及びその製法によれば、食品として安全性が確かな酒
等の製造段階で得られる酒粕又は米糠発酵エキス粕を原
料としているため、食品と同様の感覚で安心して手軽に
摂取することができ、また副作用等のダメージを受ける
こともないため、日常的および継続的な癌の予防および
治療に最適である。
As shown and described above, according to the apoptosis-inducing substance comprising the sake lees or the fermented rice bran extract lees of the present invention and the method for producing the same, the sake lees obtained at the stage of producing liquor and the like, which are safe as food, are obtained. Or, using rice bran fermented extract lees as a raw material, it can be easily and safely ingested with the same feeling as food, and there is no damage such as side effects, so daily and continuous prevention and treatment of cancer Ideal for

【0032】また、従来は廃棄物とされていた前記酒粕
や米糠発酵エキス粕を利用して、新たに癌の予防や治療
に用いることができるアポトーシス誘導物質を得ること
ができるため、原料が安価に入手でき、さらに廃棄物対
策にも貢献できる。
Further, by using the above-mentioned sake lees and fermented rice bran extract lees, which were conventionally discarded, it is possible to newly obtain an apoptosis-inducing substance which can be used for the prevention and treatment of cancer. And contribute to waste management.

【図面の簡単な説明】[Brief description of the drawings]

【図1】この発明の一実施例を示す概略工程図である。FIG. 1 is a schematic process drawing showing one embodiment of the present invention.

【図2】実験1の酒粕のエタノール抽出物による癌細胞
の増殖抑制作用を示すグラフである。
FIG. 2 is a graph showing the cancer cell growth inhibitory effect of the ethanol extract of sake lees in Experiment 1.

【図3】実験2の酒粕のエタノール抽出物によって断片
化されたDNAの分布状態を示す模式図である。
FIG. 3 is a schematic diagram showing a distribution state of DNA fragmented by an ethanol extract of sake lees in Experiment 2.

【図4】実験3の米糠発酵エキス粕のエタノール抽出物
による癌細胞の増殖抑制作用を示すグラフである。
FIG. 4 is a graph showing the cancer cell growth inhibitory effect of the ethanol extract of the rice bran fermented extract lees in Experiment 3.

【図5】実験4の米糠発酵エキス粕のエタノール抽出物
によって断片化されたDNAの分布状態を示す模式図であ
る。
FIG. 5 is a schematic diagram showing a distribution state of DNA fragmented by an ethanol extract of rice bran fermented extract lees in Experiment 4.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 村松 浩一郎 愛知県西尾市下町丸山5番地 株式会社相 生発酵内 (72)発明者 樋▲廻▼ 博重 三重県安芸郡河芸町南黒田554 Fターム(参考) 4B018 MD91 ME08 MF01 MF06 4B028 AC06 AG01 AP22 AS15 4C088 AB74 AC04 AC14 BA08 BA10 BA11 CA06 CA08 CA11 CA12 NA14 ZB26 ZC41  ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Koichiro Muramatsu 5 Maruyama, Shimomachi, Nishio-shi, Aichi Pref. Aioi Fermentation Co., Ltd. Reference) 4B018 MD91 ME08 MF01 MF06 4B028 AC06 AG01 AP22 AS15 4C088 AB74 AC04 AC14 BA08 BA10 BA11 CA06 CA08 CA11 CA12 NA14 ZB26 ZC41

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 酒粕又は米糠発酵エキス粕の有機溶媒抽
出物よりなることを特徴とする酒粕又は米糠発酵エキス
粕よりなるアポトーシス誘導物質。
1. An apoptosis-inducing substance comprising sake lees or rice bran fermented extract lees, comprising an organic solvent extract of sake lees or fermented rice bran extract lees.
【請求項2】 酒粕又は米糠発酵エキス粕に有機溶媒を
加えて攪拌し抽出し、その後遠心分離して上清を得、該
上清を濃縮することを特徴とする酒粕又は米糠発酵エキ
ス粕よりなるアポトーシス誘導物質の製法。
2. A sake lees or a rice bran fermented extract lees, comprising adding an organic solvent to the sake lees or the rice bran fermented extract lees, stirring and extracting, and then centrifuging to obtain a supernatant, and concentrating the supernatant. For producing apoptosis-inducing substances.
JP11234436A 1999-08-20 1999-08-20 Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production Pending JP2001058953A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11234436A JP2001058953A (en) 1999-08-20 1999-08-20 Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11234436A JP2001058953A (en) 1999-08-20 1999-08-20 Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production

Publications (1)

Publication Number Publication Date
JP2001058953A true JP2001058953A (en) 2001-03-06

Family

ID=16970988

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11234436A Pending JP2001058953A (en) 1999-08-20 1999-08-20 Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production

Country Status (1)

Country Link
JP (1) JP2001058953A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005325100A (en) * 2004-04-12 2005-11-24 Hakutsuru Shuzo Kk Dna synthase inhibitor, dna topoisomerase inhibitor, human neovascularization inhibitor, human cancer cell proliferation inhibitor, and health food and cosmetic
JP2006273822A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Cosmetic containing clear liquor (shochu) lees
JP2015232072A (en) * 2014-06-09 2015-12-24 共栄化学工業株式会社 Cosmetic
CN109805393A (en) * 2019-03-27 2019-05-28 北京工商大学 A kind of vinasse extract and its preparation method and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08168378A (en) * 1994-01-28 1996-07-02 Kirindou:Kk Enzyme inhibitor
WO1998020884A1 (en) * 1996-11-08 1998-05-22 Takara Shuzo Co., Ltd. Apoptosis inducers
JPH11196849A (en) * 1998-01-09 1999-07-27 Ogita Bio Science Kenkyusho:Kk Extraction of antimelanin substance-containing material and fractionation and purification of antimelanin substance

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08168378A (en) * 1994-01-28 1996-07-02 Kirindou:Kk Enzyme inhibitor
WO1998020884A1 (en) * 1996-11-08 1998-05-22 Takara Shuzo Co., Ltd. Apoptosis inducers
JPH11196849A (en) * 1998-01-09 1999-07-27 Ogita Bio Science Kenkyusho:Kk Extraction of antimelanin substance-containing material and fractionation and purification of antimelanin substance

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005325100A (en) * 2004-04-12 2005-11-24 Hakutsuru Shuzo Kk Dna synthase inhibitor, dna topoisomerase inhibitor, human neovascularization inhibitor, human cancer cell proliferation inhibitor, and health food and cosmetic
JP2006273822A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Cosmetic containing clear liquor (shochu) lees
JP2015232072A (en) * 2014-06-09 2015-12-24 共栄化学工業株式会社 Cosmetic
CN109805393A (en) * 2019-03-27 2019-05-28 北京工商大学 A kind of vinasse extract and its preparation method and application
CN109805393B (en) * 2019-03-27 2022-02-25 北京工商大学 Vinasse extract and preparation method and application thereof

Similar Documents

Publication Publication Date Title
TWI782283B (en) Use of walnut oligopeptide powder
KR101533600B1 (en) Manufacturing Method for Allomyrina dichotoma extract having anti-Obesity effect and Anti-Obesity Composition Containing the same
CN104450826B (en) A kind of coriolan extract and preparation method and application
NZ586941A (en) Fermentation with Pantoea agglomerans
JP2017222601A (en) Neurodegenerative disease therapeutic agent
CN102167726A (en) Method for separating and extracting active polypeptide and immune ribonucleic acid by utilizing blood and spleen of animal
JP2001058953A (en) Apoptosis inducer derived from sake-lees or rice bran fermented extract lees and its production
CN108707181B (en) Bitter gourd polypeptide for inhibiting tumor cell proliferation as well as preparation method and application thereof
CN114480249B (en) Application of Pinctada martensii Bei Nianye in extracting exosomes, exosomes and extraction method and application thereof
CN115369047A (en) Kluyveromyces marxianus strain and application thereof
JP2002114701A (en) Composition for improving lipid metabolism
JP6273614B2 (en) Hesperetin derivative exhibiting gene repair activating action and method for producing the same
JP3983514B2 (en) Apoptosis inducer
JP2001097872A (en) Red wine extract and method of its production
JP2011055819A (en) Food having estrogen activity by rhizopus microsporus var. oligosporus fermentation of soybean, and method for producing the same
KR101774701B1 (en) Skate Collagen Peptides With Activity Of Anti-Obesity
KR100335578B1 (en) Composition for preventing carcinogenesis containing Viscum album extract
CN1171630C (en) LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same
KR20210015272A (en) Dendropanax morbifera complex extracts for improving liver and kidney, Manufacturing method thereof and Health functional food containing the same
CN109985095A (en) A method of preparing Shuanghuanglian oral liquid for livestock clarification preparation
CN116036153B (en) Use of hops extract in the preparation of a product for the treatment or prevention of depression, complications of depression, anxiety
CN114699440B (en) Kudzu root exosome and bone marrow mesenchymal stem cell osteogenic differentiation inducer based on kudzu root exosome
JPH08196268A (en) Growth promoter for lactic acid bacteria
JP7013052B2 (en) Nanovesicles derived from enhydrobacter bacteria and their uses
CN113861306A (en) Degradation method of porphyra haitanensis polysaccharide and anti-aging activity application thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100413